PROTON THERAPY THE UP-AND-COMING MARKET! The Corporate Strategic Intelligence you need!

Transcription

1 PROTON THERAPY THE UP-AND-COMING MARKET! The Corporate Strategic Intelligence you need!

2 The World s first Proton Therapy Market Report! THE GLOBAL PROTON THERAPY MARKET WILL REACH US$ 2.2 BILLION IN 2032, GROWING BY 9% ANNUALLY. Today there are 39 proton therapy facilities for a total of 106 treatment rooms treating patients around the world, representing merely 0.8% of all conventional radiotherapy systems. By 2017 there will be 255 operational proton therapy treatment rooms. Proton therapy remains a niche market however it is just up-and-coming and growing fast. It has been subject to substantial interest in the past decade and significant growth in proton treatment facilities around the world is expected in the foreseeable future. In 2011, the global proton therapy devices market reached US$ 350 million. We project the global addressable market at 1,000 particle therapy treatment rooms, valued at US$ 2.2 billion (including services) by 2032, showing an average annual growth of 9% from 2011 to IBA clearly dominated the world market for the past 20 years. However for several years, other vendors, such as Varian, have been increasing their market share. For the year 2017, we estimate that IBA will hold just over 30% of the world particle therapy market, followed by Varian with 15% and by Mitsubishi and Hitachi holding a 9% market share each. The three Japanese particle therapy manufacturers, while mostly active in Japan for the past two decades, are now developing their strategies to be more active worldwide. The primary purpose of this proton therapy MarketR TM report is to provide a comprehensive review of the market situation and analyze trends to the year In particular, this report provides you with an insight on the proton therapy global market, including: Market size and shares; Future trends and potential to 2032; Maps and list of all operational PT facilities; Maps and list of future PT centers to 2017; Investments involved in a PT center; Profile of PT competitors; As well as carbon therapy. The Proton Therapy Global MarketR TM report may prove valuable for industry insiders, finance professionals (analysts, investors), media, as well as potential new proton therapy centers, etc The report has been prepared by Paul-Emmanuel GOETHALS, MBA, Founder and Management Consultant at CSIntell Proton Therapy MarketR TM October 2012 Page 2/5

3 Table of Contents Introduction 4 Disclaimer 6 Methodology 7 Executive Summary 8 Overview 10 Health Information 12 General 13 Cancer data 15 Radiotherapy equipment in the world 18 Current Market 21 Overview 22 Operational Particle Therapy sites 23 Operational PT sites: Competitors 31 Market Next Five Years 34 The World Market in The World Market in 2017: Competitors 43 USA in Europe in Asia in Japan in Rest of the World in Global Perspective Overview 56 Perspective in Treatment Rooms 58 Perspective in Value (US$) 65 Patient Statistics 71 Evolution of Patients Treated with PT 72 Patients Treated by Equipment Providers 75 Global Cost of PT treatment 76 Economics of Proton Therapy 77 Overview 78 Proton Therapy Investment 79 Proton Therapy Revenue Potential Proton Therapy MarketR TM October 2012 Page 3/5

4 Table of Contents Reimbursement 82 Overview 83 The US Case 85 The Case of France 88 Industry Players 89 Promoters of Proton Therapy 90 Competitors 92 Overview 93 Equipment Provided 94 SWOT 95 Revenues Hitachi 99 IBA 102 Mevion Medical Systems 106 Mitsubishi 110 Optivus Proton Therapy 113 ProTom 115 Siemens 117 Sumitomo 118 Varian Medical Systems 122 CPAC (Compact Particle Acceleration Corporation) 126 Appendix 128 Appendix A (list of active PT sites as of September 2012) 129 Appendix B (list of PT facilities under construction or project close to start) 131 Appendix C (list of PT facilities sorted by vendor) 134 Appendix D (list of PT facilities and their websites) 139 Total number of pages: Proton Therapy MarketR TM October 2012 Page 4/5

5 How to Order & Contact For more information please send an with your contact details to About CSIntell CSIntell provides the Corporate Strategic Intelligence you need! Paul-Emmanuel Goethals founded CSIntell as a new approach to connect Strategic Information needed by Senior Executives to business needs, in a concise and understandable way. Paul-Emmanuel has 23 years of experience in consulting, business development, intelligence and investors relations with a unique understanding of the medical and healthcare markets. Most recently he was Vice President Business Development & Capital Markets and Special Counsel to the CEO at Eckert & Ziegler Group and he was Director Corporate Business Development & Investor Relations at IBA for 11 years. Please visit us at: Contact CSIntell Paul-Emmanuel GOETHALS, MBA Founder, Management Consultant Mobile: [email protected] 2012 Proton Therapy MarketR TM October 2012 Page 5/5